Mutation Specific Kinase activity Measurements

Profiling Kinase Conformations

KinCon biolabs is a biotech startup based in Innsbruck Austria.
We are creating unique biosensors for improved kinase-inhibitor development.

The luciferase based KinCon biosensor measures drug-driven effects on kinase-activity by reflecting changes of cellular kinase conformations.

This technology allows reliable profiling of potential kinase inhibitors under physiological conditions:

  • Direct measurement in living cells
  • Cancer drug profiling in real-time 
  • Simple integration of patient mutations for precision medicine

Our vision is to improve drug development of kinase-targeted drugs through mutation-specific activity profiling with our live-cell biosensor platform.

Team

Meet the people working to provide you with new tools to assess kinase drug efficacy.

Eduard Stefan

CEO| Co-Founder

Philipp Tschaikner

CSO | co founder

Alexandra Fritz

Lab Assistant

Contact Us

KinCon biolabs GmbH

Innrain 66
6020 Innsbruck
Austria

Tel.: +43 512 507 57535
office@kincon-biolabs.eu

KinCon biolabs GmbH is a University of Innsbruck spin-off company supported by funding from the Austrian Research Promotion Agency (FFG) Spin-off Fellowship and Austria Wirtschaftsservice (AWS) Preseed program.